Literature DB >> 3026695

Uptake of free adenosine and adenosine from adenosine monophosphate by human peripheral blood lymphocytes: possible kinetic role for ecto-5'-nucleotidase in the regulation of intracellular adenosine.

T Shah, R J Simpson, A D Webster, T J Peters.   

Abstract

The role of 5'-nucleotidase in the uptake of adenosine from AMP was investigated in lymphocytes from normal subjects and patients with common variable hypogammaglobulinaemia (CVH) and chronic lymphatic leukaemia (CLL). At physiological pH, the Km values for the uptake of adenosine and of adenosine from AMP by intact cells were one order of magnitude higher than the Km values for 5'-nucleotidase. The Vmax values for the hydrolysis of AMP by 5'-nucleotidase were two orders of magnitude greater than for the uptake of adenosine itself or the uptake of adenosine from AMP by normal lymphocytes. 5'-Nucleotidase activity is clearly not rate-limiting in normal lymphocytes for uptake of adenosine from AMP in steady state conditions. Patients with common variable hypogammaglobulinaemia showed a low Vmax for 5'-nucleotidase assayed at pH 7.4 in intact cells as compared to values from control subjects. Michaelis constants (Km) for the uptake of free adenosine and adenosine from AMP as well as 5'-nucleotidase were similar compared to those obtained for controls. The uptake of adenosine moiety from AMP in CLL lymphocytes with a low Vmax for 5'-nucleotidase was also reduced, although not to the same extent as the reduction in 5'-nucleotidase activity. One CLL patient with supranormal levels of 5'-nucleotidase activity showed elevated uptake of adenosine moiety from AMP and of free adenosine. These results suggest that 5'-nucleotidase can influence the salvage of purine by lymphocytes from extracellular nucleotides but only when the enzyme activity is greatly reduced.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3026695      PMCID: PMC1542654     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

2.  Lymphocyte ecto-5'-nucleotidase deficiency in agammaglobulinemia.

Authors:  N L Edwards; D B Magilavy; J T Cassidy; I H Fox
Journal:  Science       Date:  1978-08-18       Impact factor: 47.728

3.  Lymphocyte populations with 5'-nucleotidase in chronic lymphocytic leukemia.

Authors:  R J Kanter; I A Freiberger; K R Rai; A Sawitsky
Journal:  Clin Immunol Immunopathol       Date:  1979-03

4.  Kinetic properties of 5' nucleotidase in blood lymphocytes from healthy subjects, immunodeficient patients and cord blood.

Authors:  T Shah; A D Webster; T J Peters
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

5.  De novo purine synthesis in human lymphocytes. Partial co-purification of the enzymes and some properties of the pathway.

Authors:  E McCairns; D Fahey; D Sauer; P B Rowe
Journal:  J Biol Chem       Date:  1983-02-10       Impact factor: 5.157

Review 6.  Metabolic defects in immunodeficiency diseases.

Authors:  A D Webster
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

7.  Chronic lymphocytic leukaemia: Clonal origin in a committed B-lymphocyte progenitor.

Authors:  P J Fialkow; V Najfeld; A L Reddy; J Singer; L Steinmann
Journal:  Lancet       Date:  1978-08-26       Impact factor: 79.321

8.  Lymphocyte enzyme activities in immunodeficiency syndromes with particular reference to common variable hypogammaglobulinaemia.

Authors:  T Shah; A D Webster; T J Peters
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

9.  Metabolic basis for disorders of purine nucleotide degradation.

Authors:  I H Fox
Journal:  Metabolism       Date:  1981-06       Impact factor: 8.694

View more
  3 in total

Review 1.  5'-Nucleotidase: molecular structure and functional aspects.

Authors:  H Zimmermann
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

2.  Transport of 9-(2-phosphonomethoxyethyl)adenine across plasma membrane of HeLa S3 cells is protein mediated.

Authors:  T Cihlár; I Rosenberg; I Votruba; A Holý
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

3.  Expression of ecto-5'-nucleotidase (CD73) in normal mammary gland and in breast carcinoma.

Authors:  K H Krüger; L F Thompson; M Kaufmann; P Möller
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.